Cite

HARVARD Citation

    Zhang, Q. et al. (n.d.). Systemic delivery of TLR9-activating/STAT3-blocking oligonucleotides induces leukemia regression. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record